LISTEN LIVE: Loading...

Advertisement

 

Next generation of COVID-19 vaccines may not be shots

05:03
Download
Play
A researcher manipulates proteins in a laboratory of the Tours University. The University of Tours and the French National Research Institute For Agriculture, Food And Environment (INRAE) announced on Sept. 9, 2021, the design of a nasal spray vaccine candidate against COVID-19. (Guillaume SouvantT/AFP via Getty Images)
A researcher manipulates proteins in a laboratory of the Tours University. The University of Tours and the French National Research Institute For Agriculture, Food And Environment (INRAE) announced on Sept. 9, 2021, the design of a nasal spray vaccine candidate against COVID-19. (Guillaume SouvantT/AFP via Getty Images)
This article is more than 1 year old.

The Centers for Disease Control and Prevention reports nearly 74% of Americans 5 years and older have received at least one dose of the COVID-19 vaccine. But much of the rest of the world remains unvaccinated.

That may change, with dozens of new vaccines under development. Many of those new vaccines may come in pill or nasal spray form. Brett Dahlberg of IEEE Spectrum takes a look at some of these second-generation vaccines.

This segment aired on November 23, 2021.

Advertisement

 
Play
Listen Live
/00:00
Close